AlTorress

LRCX, enters a monthly bullish trend.

Long
NASDAQ:LRCX   Lam Research Corporation
Lam Research Corp. (LRCX, $479.22) is predicted by Tickeron's A.I.dvisor to grow by 4% to $498.39 or more within the next month. Keeping in mind similar previously-analyzed scenarios where the stock trended up during the month, the odds of an Uptrend continuation are 81%. Current price $498.39 is above $371.00 the highest support line found by Tickeron A.I. Throughout the month of 11/02/20 - 12/03/20, the price experienced a +38% Uptrend. During the week of 11/25/20 - 12/03/20, the stock enjoyed a +8% Uptrend growth.

Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 03, 2020. You may want to consider a long position or call options on LRCX as a result. Tickeron A.I. detected that in 56 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 71%.

LRCX moved above its 50-day Moving Average on October 29, 2020 date and that indicates a change from a downward trend to an upward trend.

The 10-day Moving Average for LRCX crossed bullishly above the 50-day moving average on October 12, 2020. This indicates that the trend has shifted higher and could be considered a buy signal. Tickeron A.I. detected that in 13 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 81%.

Following a +3.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where LRCX advanced for three days, in 295 of 376 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.

The Aroon Indicator entered an Uptrend today. Tickeron A.I. detected that in 294 of 393 cases where LRCX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.